Anika Therapeutics, Inc. logo ANIK - Anika Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 3
SELL 0
STRONG
SELL
0

About Anika Therapeutics, Inc. (https://www.anikatherapeutics.com)

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain management family, which includes established treatments like Monovisc, Orthovisc, Cingal, and Hyvisc, all designed to alleviate discomfort from osteoarthritis. The company's joint preservation and restoration offerings are extensive, comprising approximately 150 bone-sparing joint technology products, alongside solutions for sports medicine soft tissue repair and orthopedic regenerative therapies. Furthermore, Anika leverages its HA expertise in a non-orthopedic product family, developing applications such as adhesion barriers, advanced wound care products, ophthalmic solutions, and ear, nose, and throat treatments. Anika Therapeutics, Inc. was established in 1983 and is based in Bedford, Massachusetts.

Key Executives

NAME TITLE DOB SALARY
Cheryl Renee Blanchard Executive Chair 1964 $1,410,649 USD
Stephen D. Griffin President, Principal Financial Officer, CEO & Director 1986 $818,148 USD
David Colleran Executive Vice President, General Counsel & Corporate Secretary 1972 $724,581 USD
Ian W. McLeod Senior VP, Chief Accounting Officer & Treasurer 1966 $489,601 USD
Ben Joseph Vice President of Commercial & Corporate Development
James Chase Senior Vice President of International Sales & Marketing
Lisa Funiciello VP & Chief Human Resources Officer
Matthew Hall Executive Director of Corporate Development & Investor Relations
Mira Leiwant Senior Vice President of Regulatory, Quality & Clinical Affairs

Company Peers

Peer analysis pending, check back in 1-2 minutes.